{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:49:27Z","timestamp":1770990567780,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.lfs.2012.11.015","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T01:36:15Z","timestamp":1355362575000},"page":"167-173","source":"Crossref","is-referenced-by-count":16,"title":["Novel GPR119 agonist AS1669058 potentiates insulin secretion from rat islets and has potent anti-diabetic effects in ICR and diabetic db\/db mice"],"prefix":"10.1016","volume":"92","author":[{"given":"Hiroyuki","family":"Oshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Yonetoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2012.11.015_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1464-5491.2007.02341.x","article-title":"Hypoglycaemia in type 2 diabetes","volume":"25","author":"Amiel","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.lfs.2012.11.015_bb0010","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/en.2004-0015","article-title":"Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system","volume":"145","author":"Brubaker","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2012.11.015_bb0020","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/en.2006-1608","article-title":"A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release","volume":"148","author":"Chu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2012.11.015_bb0015","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/en.2007-0966","article-title":"A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release","volume":"149","author":"Chu","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2012.11.015_bb0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/diacare.15.3.318","article-title":"Pathogenesis of NIDDM. A balanced overview","volume":"15","author":"DeFronzo","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2012.11.015_bb0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.lfs.2012.11.015_bb0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.lfs.2012.11.015_bb0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1085\/jgp.20028707","article-title":"SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells","volume":"121","author":"Eliasson","year":"2003","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.lfs.2012.11.015_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diabetes.53.1.5","article-title":"Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell","volume":"53","author":"Holz","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2012.11.015_bb0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-2004-826165","article-title":"New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells","volume":"36","author":"Holz","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.lfs.2012.11.015_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/diacare.12.3.203","article-title":"Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents","volume":"12","author":"Jennings","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2012.11.015_bb0060","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543770903153878","article-title":"GPR119 agonists for the treatment of type 2 diabetes","volume":"19","author":"Jones","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.lfs.2012.11.015_bb0065","doi-asserted-by":"crossref","first-page":"46046","DOI":"10.1074\/jbc.M108378200","article-title":"Critical role of cAMP-GEFII\u2013Rim2 complex in incretin-potentiated insulin secretion","volume":"276","author":"Kashima","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2012.11.015_bb0070","first-page":"821","article-title":"Effects of incretins on the regulation of beta-cell mass, proliferation and survival","volume":"69","author":"Kawamori","year":"2011","journal-title":"Nihon Rinsho"},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2012.11.015_bb0075","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.2337\/dc09-S315","article-title":"Incretin-based therapies: viewpoints on the way to consensus","volume":"32","author":"Nauck","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2012.11.015_bb0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1507\/endocrj1954.26.495","article-title":"Simple method for the collection of pancreatic islets by the use of Ficoll\u2013Conray gradient","volume":"26","author":"Okeda","year":"1979","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.lfs.2012.11.015_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.lfs.2012.11.015_bb0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/35041046","article-title":"cAMP-GEFII is a direct target of cAMP in regulated exocytosis","volume":"2","author":"Ozaki","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.lfs.2012.11.015_bb0095","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1210\/endo.141.12.7806","article-title":"Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats","volume":"141","author":"Perfetti","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2012.11.015_bb0100","doi-asserted-by":"crossref","first-page":"e6221","DOI":"10.1371\/journal.pone.0006221","article-title":"Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells","volume":"4","author":"Peyot","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2012.11.015_bb0105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/mend.11.5.9922","article-title":"L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells","volume":"11","author":"Safayhi","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.lfs.2012.11.015_bb0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbrc.2006.10.076","article-title":"Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells","volume":"351","author":"Sakamoto","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2012.11.015_bb0115","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1073\/pnas.78.7.4339","article-title":"Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells","volume":"78","author":"Santerre","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lfs.2012.11.015_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.lfs.2012.11.015_bb0125","doi-asserted-by":"crossref","first-page":"19333","DOI":"10.1073\/pnas.0707054104","article-title":"Essential role of Epac2\/Rap1 signaling in regulation of insulin granule dynamics by cAMP","volume":"104","author":"Shibasaki","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lfs.2012.11.015_bb0130","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2004.11.120","article-title":"Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor","volume":"326","author":"Soga","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2012.11.015_bb0135","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/diab.43.6.735","article-title":"Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?","volume":"43","author":"Taylor","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2012.11.015_bb0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2010.08.097","article-title":"Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion","volume":"400","author":"Yoshida","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2012.11.015_bb0145","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2010.10.015","article-title":"Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db\/db mice","volume":"402","author":"Yoshida","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2012.11.015_bb0155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bbrc.2010.08.141","article-title":"AS1907417, a novel GPR119 agonist, as an insulinotropic and beta-cell preservative agent for the treatment of type 2 diabetes","volume":"400","author":"Yoshida","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2012.11.015_bb0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1463-1326.2010.01315.x","article-title":"The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic beta-cell function","volume":"13","author":"Yoshida","year":"2011","journal-title":"Diabetes Obes Metab"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512007102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512007102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T06:53:32Z","timestamp":1588834412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320512007102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0024320512007102"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2012.11.015","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}